Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
Antwerp University Hospital (UZA)
mi
from
Edegem,
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
Antwerp University Hospital (UZA)
mi
from
Edegem,
Click here to add this to my saved trials
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
A Phase 3 Switchover Study of the Efficacy and Safety of BMN 701 (GILT-tagged Recombinant Human GAA) and Long-Term Study for Extended Treatment in rhGAA Exposed Subjects With Late-onset Pompe Disease
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics
Evaluation of the Effects of Insulin Peglispro (LY2605541) on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics
Evaluation of the Effects of Insulin Peglispro (LY2605541) on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Treating Prediabetes in the First Trimester
Treating Prediabetes in the First Trimester: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
UC San Diego Health System
mi
from
San Diego, CA
Treating Prediabetes in the First Trimester
Treating Prediabetes in the First Trimester: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
UC San Diego Health System
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
Barbara Davis Center
mi
from
Aurora, CO
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
Barbara Davis Center
mi
from
Aurora, CO
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated:  12/31/1969
SUNY Upstate Medical University
mi
from
Syracuse, NY
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
Status: Enrolling
Updated: 12/31/1969
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Plant-Based Dietary Intervention in Type 2 Diabetes-2
A Practice-Based, Nutrition Intervention in Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Plant-Based Dietary Intervention in Type 2 Diabetes-2
A Practice-Based, Nutrition Intervention in Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Southwest American Indian Center
mi
from
Phoenix, AZ
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Southwest American Indian Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Translational Research Institute
mi
from
Orlando, FL
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Translational Research Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical Center
mi
from
Decatur, GA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical Center
mi
from
Decatur, GA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Tulane University Health Sciences
mi
from
New Orleans, LA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Tulane University Health Sciences
mi
from
New Orleans, LA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Maine Medical Center
mi
from
Scarborough, ME
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Maine Medical Center
mi
from
Scarborough, ME
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
MedStar Community Clinical Research Center
mi
from
Hyattsville, MD
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
MedStar Community Clinical Research Center
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Health Partners Riverside Clinic
mi
from
Minneapolis, MN
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Health Partners Riverside Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Omaha VA Medical Center
mi
from
Omaha, NE
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Omaha VA Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Beth Israel Med Ctr
mi
from
New York, NY
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated:  12/31/1969
Orlando Va Medical Center
mi
from
Orlando, FL
Vitamin D and Type 2 Diabetes Study
Vitamin D and Type 2 Diabetes Study
Status: Enrolling
Updated: 12/31/1969
Orlando Va Medical Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Harnessing mHealth and Social Support to Improve Diabetes Related Health Behavior for Inner-city Patients
Trial to Examine Text-based mHealth for Emergency Department Patients With Diabetes With Family And Friend Network Supporter
Status: Enrolling
Updated:  12/31/1969
LAC+USC
mi
from
Los Angeles, CA
Harnessing mHealth and Social Support to Improve Diabetes Related Health Behavior for Inner-city Patients
Trial to Examine Text-based mHealth for Emergency Department Patients With Diabetes With Family And Friend Network Supporter
Status: Enrolling
Updated: 12/31/1969
LAC+USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion
The Effects of GIP and/or Xenin-25, With and Without Atropine, on Insulin Secretion in Humans With Pre-diabetes
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion
The Effects of GIP and/or Xenin-25, With and Without Atropine, on Insulin Secretion in Humans With Pre-diabetes
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Fresno, CA
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Los Alamitos, CA
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Palm Springs, CA
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
San Diego, CA
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus (DUAL™ V - Basal Insulin Switch)
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials